EUCTR2007-004144-74-GB进行中（未招募）1 期
A comparison of the effects of insulin Detemir with insulin Glargine on weight gain in female adolescents and young adults with Type 1 Diabetes (T1D) on a basal bolus regime - A comparison of Insulins Detemir and Glargine in Girls with Diabetes
适应症
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 入组人数
- 97
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
入选标准
- •Type 1 diabetes, diagnosed over 1 year, or C-peptide negative
- •Postmenarchal OR in late puberty (Tanner breast stage 4 or 5)
- •HbA1c <12%
- •BMI-SDS less than or equal to +2.5 for age
- •No active or untreated concurrent disease
- •Written informed, witnessed consent
- •Are the trial subjects under 18? yes
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) no
- •F.1.3.1 Number of subjects for this age range
排除标准
- •Non-type 1 diabetes mellitus including those secondary to an existing pathology.
- •Any other physical or psychological disease likely to interfere with the normal conduct of the study and interpretation of the results.
- •Pregnant or breast feeding women
- •Females of reproductive age who are unwilling to take appropriate measures of contraception
- •Patients taking medication likely to affect glucose metbolism eg metformin or oral corticosteroids
研究者
相似试验
已完成
3 期
Determir versus Glargine for weight gain in adolescents with type 1 diabetesTopic: Medicines for Children Research Network, Diabetes Research NetworkSubtopic: Type 1, All DiagnosesDisease: All Diseases, Insulin switch, Metabolic, PaediatricNutritional, Metabolic, EndocrineType 1 diabetesISRCTN49492872Cambridge University Hospitals NHS Foundation Trust (UK)97
进行中（未招募）
不适用
Comparison of the effect of insulin detemir and NPH insulin on dawn phenomenon in patients with Type 1 diabetes An open-labelled, randomised, cross-over, multi-center trial comparing the effect of insulin detemir versus NPH insulin as basal insulins on dawn phenomenon and the glycaemic control in patients with Type 1 diabetes treated on a basal-bolus regimen - Dawn phenomenon – insulin detemirType 1 diabetes mellitus, dawn phenomenonEUCTR2005-003877-26-HUational Centre for Diabetes Care, 1st Dept. Medicine, Diabetes Unit
进行中（未招募）
1 期
The effect of insulin detemir in combination with liraglutide and metformin compared to liraglutide and metformin in subjects with type 2 diabetes. A 26-week, randomised, open-label, parallel-group, multicentre, multinational trial with a 26-week extensioType 2 diabetesMedDRA version: 9.1 Level: LLT Classification code 10045242 Term: Type II diabetes mellitusEUCTR2007-005317-19-GBovo Nordisk A/S940
进行中（未招募）
不适用
The effect of insulin detemir in combination with liraglutide and metformin compared to liraglutide and metformin in subjects with type 2 diabetes. A 26-week, randomised, open-label, parallel-group, multicentre, multinational trial with a 26-week extension - NDEUCTR2007-005317-19-ITOVO NORDISK940
进行中（未招募）
1 期
The effect of insulin detemir in combination with liraglutide and metformin compared to liraglutide and metformin in subjects with type 2 diabetes.A 26-week, randomised, open-label, parallel-group, multicentre, multinational trial with a 26-week extensioEUCTR2007-005317-19-FRovo Nordisk A/S940